Actemra 162mg/0,9ml - Switzerland (Tocilizumab) 162mg

Actemra 162mg/0.9ml is a prescription medication containing tocilizumab, used for inflammatory conditions. It is supplied as a prefilled syringe for subcutaneous injection. This Swiss-origin product is designed for convenient at-home administration.

Strength

162mg

Manufacturer / TM Owner

Roche Pharma Switzerland

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Actemra 162mg/0.9ml is used to treat moderate to severe rheumatoid arthritis in adults. It may also be prescribed for giant cell arteritis or polyarticular juvenile idiopathic arthritis in appropriate patients. The medication helps reduce inflammation and manage symptoms like joint pain and swelling.

Side Effects

This injectable solution works by targeting specific pathways in the immune system to decrease inflammation. Users may experience reduced joint stiffness and improved mobility over time. Some patients report gradual symptom relief as the medication takes effect.

Precautions & Warnings

Store Actemra 162mg/0.9ml in the refrigerator and protect it from light. Do not freeze or shake the prefilled syringe. Keep the medication out of reach of children and pets. Dispose of used syringes in a sharps container as directed.

Avoid Interactions

Actemra may interact with other immunosuppressants or live vaccines. Caution is advised when combining with medications that affect liver enzymes, such as certain antifungals or antibiotics. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

It is used to treat rheumatoid arthritis, giant cell arteritis, and polyarticular juvenile idiopathic arthritis.

It is given as a subcutaneous injection, typically once every one to two weeks.

Common side effects may include injection site reactions, headache, or upper respiratory infections.

It is available by prescription only and may be purchased from licensed pharmacies.

Consult your healthcare provider for personalized advice regarding pregnancy or breastfeeding.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.